CX 2026 Registration
CX Executive Board
CX 2026 Programme
CX 2026 – The 48th Charing Cross Symposium
The Charing Cross (CX) Symposium continues to set the standard in vascular and endovascular education, shaping the future of practice worldwide. CX 2026 marked the final chapter of our current three-year cycle, designed to spark debate on the biggest controversies in the field. Our distinguished faculty of global experts critically examined the evidence, exchanged perspectives, and worked towards building consensus on the issues that matter most.
Consensus was the defining theme for CX 2026. We welcomed an international community of specialists, educators, and innovators to tackle the pressing challenges in vascular and endovascular medicine—challenges that directly impact patient outcomes and clinical decision-making.
In 2024, CX found a new home at ExCeL London, unlocking fresh opportunities for immersive, hands-on learning. The expanded workshop programme has gone from strength to strength, offering delegates practical skills alongside groundbreaking evidence and innovation. In 2026, we returned once again to London’s premier conference and exhibition venue to deliver an agenda packed with cutting-edge science, expert debate, and future-shaping education.
Stay connected—sign up for the CX Newsletter and be the first to hear the latest updates.
CX Co-Chairs
Latest CX news
CX 2021: Abdominal Aortic Highlights
CX 2021 has finished but that does not mean you have missed your opportunity to view all the high-quality content that was on display. All our sessions, from both Livestream 1 and Livestream 2, are available on-demand [...]
Experts go head-to-head in Acute Stroke session
Barbara Rantner (Munich, Germany; CX Executive Board Member) discusses some of the upcoming highlights from the session including an array of debates which are outlined below and which Rantner notes "really matter to the [...]
Vascular Trauma Controversies at CX 2021
Christopher Aylwin (UK) talks about resuscitative endovascular balloon occlusion of the aorta (REBOA), which he notes will likely be the biggest controversial topic in this year’s Vascular Trauma session. For some the procedure [...]





